HDAC9 and central nervous system cancer: In summary, enhanced tumor cell death and reduced tumor cell proliferation as well as increased acetylation of p53, and increased mRNA expression of PUMA, Bax and p21 were simultaneously observed with HDAC inhibition in MPT0B291-treated glioma cells (Figure 7H).